Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1997-11-14
2000-08-01
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 8, A61K 3819
Patent
active
06096300&
ABSTRACT:
The present invention provides purified and isolated chemokine protein, fragments and polypeptide analogs thereof, antibodies thereto, and materials and methods for the recombinant production thereof. These products are useful in therapeutics, such as the treatment of myeloproliferative diseases, as well as in diagnostic and medical imaging applications.
REFERENCES:
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 5037630 (1991-08-01), Fritzberg et al.
patent: 5179078 (1993-01-01), Rollins et al.
patent: 5413778 (1995-05-01), Kunkel et al.
patent: 5602008 (1997-02-01), Wilde et al.
Ahuja, S.K. et al., "Chemokine receptors and molecular mimicry," Immunology Today, 15(6):281-287 (1994).
Alkhatib, G. et al., "CC CKR5: A RANTES, MIP-1.alpha., MIP-1.beta. Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1," Science, 272:1955-1958 (Jun. 28, 1996).
Avanzi, G.C. et al., "Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features," British Journal of Haematology, 69:359-366 (1988).
Baggiolini, M. et al., "Interleukin-8 and Related Chemotactic Cytokines-CXC and CC Chemokines," Advances in Immunology, 55:97-179 (1994).
Better, M. et al., "Escherichia coli Secretion of an Active Chimeric Antibody Fragment," Science, 240:1041-1043 (May 20, 1988).
Bitter, G.A. et. al., "Secretion of foreign proteins from Saccharomyces cerevisiae directed by .alpha.-factor gene fusions," Proc. Natl. Acad. Sci., USA, 81:5330-5334 (Sep., 1984).
Brown, K.D. et al., "A Family of Small Inducible Proteins Secreted by Leukocytes are Members of a New Superfamily that Includes Leukocyte and Fibroblast-Derived Inflammatory Agents Growth Factors, and Indicators of Various Activation Processes," J. Immunology, 42(2):679-687 (Jan. 15, 1989).
Broxmeyer, H.E. et al., "Enhancing and Suppressing Effects of Recombinant Murine Macrophage Inflammatory Proteins on Colony Formation In Vitro by Bone Marrow Myeloid Progenitor Cells," Blood, 76(6):1110-1116 (Sep. 15, 1990).
Broxmeyer, H.E. et al., "Comparative Analysis of the Human Macrophage Inflammatory Protein Family of Cytokines (Chemokines) on Proliferation of Human Myeloid Progenitor Cells," J. Immunology, 150(8):3448-3458 (Apr. 15, 1993).
Broxmeyer, H.E. et al., "Human chemokines: enhancement of specific activity and effects in Vitro on normal and leukemic progenitors and a factor-dependent cell line and in Vivo in mice," Ann. Hematol., 71:235-246 (1995).
Chang, H.C. et al., "Cloning and expression of a .gamma.-interferon-inducible gene in monocytes: a new member of a cytokine gene family," International Immunology, 1(4):388-397 (1989).
Chang, J-Y, "Thrombin specificity: Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate," Eur. J. Biochem., 151:217-224 (1985).
Charo, I.F. et al., "Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails," Proc. Nat. Acad. Sci., 91:2752-2756 (Mar., 1994).
Choe, H. et al., "The .beta.-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates," Cell, 85:1135-1148 (Jun. 28, 1996).
Clark-Lewis, I. et al., "Structure-Activity Relationships of Interleukin-8 Determined Using Chemically Synthesized Analogs," J. Biological Chemistry., 266(34):23128-23134 (Dec. 5, 1991).
Clark-Lewis, I. et al., "Structure-Activity Relationships of Chemokines," J. Leukoc. Biol., 57:703-711 (May, 1995).
Cocchi, F. et al., "Identification of RANTES, MIP-1.alpha., and MIP-1.beta. as the Major HIV-Suppressive Factors Produced by CD8.sup.+ T Cells," Science, 270:1811-1815 (Dec. 15, 1995).
Combadiere, C. et al., "Cloning and Functional Expression of a Human Eosinophil CC Chemokine Receptor," J. Biological Chemistry, 270(27):16491-16494 (Jul. 14, 1995).
Deng, H. et al., "Identification of a major co-receptor for primary isolates of HIV-1," Nature, 381:661-666 (Jun. 20, 1996).
Devi, S. et al., "Biologic Activities of the .beta.-Chemokine TCA3 on Neutrophils and Macrophages," J. Immunology., 154:5376-5383 (1995).
Doranz, B.J. et al., "A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the .beta.-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors," Cell, 85:1149-1158 (Jun. 28, 1996).
Dragic, T. et al., "HIV-1 entry into CD4.sup.+ cells is mediated by the chemokine receptor CC-CKR-5," Nature, 381:667-673 (Jun. 20, 1996).
Dunlop D.J. et al., "Demonstration of Stem Cell Inhibition and Myeloprotective Effects of SCI/rhMIP1.alpha. In vivo," Blood, 79(9):2221-2225 (May 1, 1992).
Ellis, L. et al., "Replacement of Insulin Receptor Tyrosine Residues 1162 and 1163 Compromises Insulin-Stimulated Kinase Activity and Uptake of 2-Deoxyglucose," Cell, 45:721-732 (Jun. 6, 1986).
Fauci, A.S., "An elusive soluble suppressor," Nature, 378:561 (Dec. 7, 1995).
Feng, Y. et al., "HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor," Science, 272:872-877 (May 10, 1996).
Harada, A. et al., "Essential involvement of interleukin-8 (IL-8) in acute inflammation," J. Leukocyte Biology, 56:559-564 (Nov., 1994).
Ho, D.D., "Viral Counts Count in HIV Infection," Science, 272:1124-1125 (May 24, 1996).
Holmes, W.E. et al., "Structure and Functional Expression of a Human Interleukin-8 Receptor," Science, 253:1278-1280 (Sep. 13, 1991).
Horuk, R. et al., "Purification, Receptor Binding Analysis, and Biological Characterization of Human Melanoma Growth Stimulating Activity (MGSA)," J. Biological Chemistry, 268(1):541-546 (Jan. 5, 1993).
Horuk, R., "Molecular Properties of the Chemokine Receptor Family," TIPS, 15:159-165 (May, 1994).
Hromas, R. et al., "Exodus, A Novel Chemokine that Inhibits Proliferation of Hematopoietic Progenitors and Production of HIV," Blood, 88(10 Suppl. 1 part 1-2): 339A (1996). Abstract 1344.
Hromas, R. et al., "Isolation and Characterization of Exodus-2, a Novel C-C Chemokine with a Unique 37-Amino Acid Carboxyl-Terminal Extension," J. Immunology, 159:2554-2558 (1997).
Hromas, R. et al., "Cloning and characterization of exodus, a novel .beta.-chemokine." Blood, 89(9):3315-3322 (May, 1997).
Keller, H.U. et al., "Re-Assessment of Boyden's Technique for Measuring Chemotaxis," J. Immunological Methods, 1:165-168 (1972).
Kuna, P. et al., "RANTES, a Monocyte and T Lymphocyte Chemotactic Cytokine Releases Histamine from Human Basophils," J. Immunology, 49(2):636-642 (Jul. 15, 1992).
Kurjan J. et al., "Structure of a Yeast Pheromone Gene (MF.alpha.): A Putative .alpha.-Factor Precursor Contains Four Tandem Copies of Mature .alpha.-Factor," Cell, 30:933-943 (Oct., 1982).
Laning, J. et al., "Inhibition of In Vivo Tumor Growth by the .beta. Chemokine, TCA3," J. Immunology, 153:4625-4635 (1994).
Lord, B.I. et al., "Macrophage-Inflammatory Protein Protect Multipotent Hematopoietic Cells From the Cytotoxic Effects of Hydroxyurea In Vivo," Blood, 79(10):2605-2609 (May 15, 1992).
Luo, Y. et al., "Biologic Activities of the Murine .beta.-Chemokine TCA3," J. Immunology, 153:4616-4624 (1994).
Mantel, C. et al., "Polymerization of murine macrophage inflammatory protein 1.alpha. inactivates its myelosuppressive effects in vitro: The active form is a monomer," Proc. Natl. Acad. Sci., USA, 90:2232-2236 (Mar., 1993).
Martinet, Y. et al., "Blood monocyte chemotaxis," J. Immunological Methods, 174:209-214 (1994).
Matsushima, K. et al., "Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line," J. Experimental Medicine, 169:1485-1490 (1989).
Meurer, R. et al., "Formation of Eosinophilic and Monocytic Intradermal Inflammatory Sites in the Dog by Injection of Human RANTES but not Human Monocyte Chemoattractant Protein 1, Human Macrophage Inflammatory Protein 1.alpha., or Human Interleukin 8," J. Exp. Med., 178:1913-1921 (Dec., 1993).
Miller, M.D. et al., "A Novel Polypeptide Secreted by Activated Human T Lymphocytes," J. Immunology, 3(9):2907-2916 (Nov. 1, 1989).
Murphy, P.M. et al., "Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 Receptor,"
Advanced Research and Technology Institute
Draper Garnette D.
LandOfFree
Treatment of myeloproliferative disease with exodus chemokine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of myeloproliferative disease with exodus chemokine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of myeloproliferative disease with exodus chemokine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-660955